We are live on !
Find out more
Pier Capital Portfolio holdings
AUM
$755M
Turnover
32.67%
1-Year Est. Return
94.38%
This Fund
S&P 500
This Quarter Est. Return
+19.26%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$656M
AUM Growth
+$58.7M
(+9.8%)
Cap. Flow
-$21.6M
Cap. Flow % of AUM
Cap. Flow %
-3.29%
Top 10 Holdings %
Top 10 Hldgs %
19.02%
Holding
133
New
17
Increased
18
Reduced
73
Closed
12
Avg Time Held
1.9
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Establishment Labs
ESTA
|
+$8.8M |
| 2 |
Certara
CERT
|
+$7.9M |
| 3 |
nCino
NCNO
|
+$7.24M |
| 4 |
Perella Weinberg Partners
PWP
|
+$6.96M |
| 5 |
Century Communities
CCS
|
+$5.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Levi Strauss
LEVI
|
+$8.44M |
| 2 |
Beacon Roofing Supply, Inc.
BECN
|
+$7.16M |
| 3 |
Dutch Bros
BROS
|
+$6.66M |
| 4 |
Exponent
EXPO
|
+$6.48M |
| 5 |
Quanterix
QTRX
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Healthcare | 23.22% |
| 3 | Industrials | 20.07% |
| 4 | Consumer Staples | 9.45% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Structure Therapeutics
GPCR
$1.5B
| $4.12M | 0.63% |
198,478
-14,042
| -7% | -$309K |
2023 Q4
6 quarters
|
|
77
DELISTED
Crinetics Pharmaceuticals
CRNX
| $4.1M | 0.63% |
142,611
+29,199
| +26% | +$902K |
2023 Q4
6 quarters
|
|
78
Saia
SAIA
$8.91B
| $4.06M | 0.62% |
+14,819
| New | +$4.22M |
2025 Q2
0 quarters
|
|
79
DELISTED
Chart Industries
GTLS
| $3.97M | 0.61% |
24,132
-22,815
| -49% | -$3.35M |
2024 Q3
3 quarters
|
|
80
Anavex Life Sciences
AVXL
$121M
| $3.91M | 0.6% |
424,148
-31,279
| -7% | -$267K |
2024 Q4
2 quarters
|
|
81
Surgery Partners
SGRY
$1.91B
| $3.88M | 0.59% |
174,544
+173,766
| +22,335% | +$3.86M |
2021 Q4
14 quarters
|
|
82
Guardant Health
GH
$21.3B
| $3.77M | 0.57% |
72,402
-50,555
| -41% | -$2.26M |
2024 Q2
4 quarters
|
|
83
Core Scientific
CORZ
$4.33B
| $3.73M | 0.57% |
+218,558
| New | +$2.19M |
2025 Q2
0 quarters
|
|
84
Capricor Therapeutics
CAPR
$390M
| $3.65M | 0.56% |
367,717
+13,536
| +4% | +$143K |
2025 Q1
1 quarter
|
|
85
Xometry
XMTR
$5.21B
| $3.6M | 0.55% |
+106,525
| New | +$3.12M |
2025 Q2
0 quarters
|
|
86
Lantheus
LNTH
$6.51B
| $3.59M | 0.55% |
43,907
-6,705
| -13% | -$589K |
2024 Q1
5 quarters
|
|
87
Olema Pharmaceuticals
OLMA
$576M
| $3.28M | 0.5% |
771,072
-46,889
| -6% | -$209K |
2024 Q4
2 quarters
|
|
88
Ceco Environmental
CECO
$3.32B
| $3.23M | 0.49% |
+113,946
| New | +$2.84M |
2025 Q2
0 quarters
|
|
89
Telix Pharmaceuticals
TLX
$3.63B
| $3.04M | 0.46% |
+188,992
| New | +$3.17M |
2025 Q2
0 quarters
|
|
90
Trex
TREX
$4.66B
| $3M | 0.46% |
55,108
-2,885
| -5% | -$164K |
2025 Q1
1 quarter
|
|
91
Kodiak Gas Services
KGS
$4.77B
| $2.02M | 0.31% |
59,005
-100,454
| -63% | -$3.48M |
2024 Q2
4 quarters
|
|
92
Tradeweb Markets
TW
$23.9B
| $1.24M | 0.19% |
8,459
-346
| -4% | -$48.3K |
2022 Q4
10 quarters
|
|
93
Comfort Systems
FIX
$50.6B
| $1.14M | 0.17% |
2,132
-56
| -3% | -$24.4K |
2025 Q1
1 quarter
|
|
94
Pinterest
PINS
$12.4B
| $1.13M | 0.17% |
31,623
-882
| -3% | -$26.8K |
2019 Q2
24 quarters
|
|
95
Evercore
EVR
$9.8B
| $995K | 0.15% |
3,685
-88
| -2% | -$19.4K |
2022 Q3
11 quarters
|
|
96
Texas Roadhouse
TXRH
$11.1B
| $976K | 0.15% |
5,208
-134
| -3% | -$24K |
2022 Q2
12 quarters
|
|
97
Cheniere Energy
LNG
$59.8B
| $973K | 0.15% |
3,995
-94
| -2% | -$21.8K |
2022 Q4
10 quarters
|
|
98
MongoDB
MDB
$27.2B
| $939K | 0.14% |
4,473
-105
| -2% | -$19.4K |
2023 Q2
8 quarters
|
|
99
Dynatrace
DT
$17.7B
| $899K | 0.14% |
16,281
-385
| -2% | -$19.3K |
2022 Q4
10 quarters
|
|
100
DELISTED
CyberArk
CYBR
| $620K | 0.09% |
1,523
-64
| -4% | -$23.3K |
2024 Q4
2 quarters
|
|
Similar funds
Pier Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Pier Capital held 133 positions worth $656M, up 9.8% from $597M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Pier Capital withdrew a net $21.6M in Q2 2025, closing 12 positions and reducing 73 holdings. Its most notable exit was Levi Strauss, an estimated $8.44M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Pier Capital opened a new position in Establishment Labs worth $10.8M.
- Pier Capital's largest Q2 2025 buy was Establishment Labs: 252,318 shares worth $10.8M.
- Pier Capital added most to Portillo's in Q2 2025, an estimated $4.62M increase.
- Pier Capital's biggest Q2 2025 reduction was Houlihan Lokey, cutting an estimated $5.5M.
- Pier Capital fully exited Levi Strauss in Q2 2025, selling an estimated $8.44M.
- Pier Capital's ten largest holdings make up 19% of its $656M portfolio in Q2 2025.
- Pier Capital opened 17 new positions and closed 12 in Q2 2025.
- Pier Capital's portfolio value rose 9.8% quarter-over-quarter to $656M.
Based on Pier Capital's 13F filing for Q2 2025, filed 5 Aug 2025.